[Federal Register: April 7, 2004 (Volume 69, Number 67)]
[Rules and Regulations]               
[Page 18255]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

21 CFR Parts 201, 606, and 610

[Docket No. 2002N-0204]

Bar Code Label Requirement for Human Drug Products and Biological 
Products; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.


SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of February 26, 2004 (69 FR 
9120). The document included typographical and inadvertent errors. This 
document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Philip L. Chao, Office of Policy and 
Planning (HF-23), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-0587.

SUPPLEMENTARY INFORMATION: In FR Doc. 04-4249, appearing on page 9120 
in the Federal Register of Thursday, February 26, 2004, the following 
corrections are made:

1. On page 9151, in the third column, the first sentence of the first 
full paragraph, is corrected to read ``We estimate that the rule 
provides net benefits to society of $4.3 billion to $4.5 billion 
annually, depending on whether a discount rate of 3 percent or 7 
percent is used.''
2. On page 9167, in the first column, the first sentence under the 
heading ``P. Small Business Analysis and Discussion of Alternatives'' 
is corrected to read ``For the reasons cited in the following 
paragraphs, the agency certifies that the final rule will not have a 
significant economic impact on a substantial number of small 

    Dated: March 31, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-7815 Filed 4-6-04; 8:45 am]